[go: up one dir, main page]

WO2008038140A3 - Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées - Google Patents

Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées Download PDF

Info

Publication number
WO2008038140A3
WO2008038140A3 PCT/IB2007/003463 IB2007003463W WO2008038140A3 WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3 IB 2007003463 W IB2007003463 W IB 2007003463W WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypropylene glycol
alkyl ether
pharmaceutical compositions
glycol alkyl
foamable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/003463
Other languages
English (en)
Other versions
WO2008038140A2 (fr
Inventor
Doron Freidman
Dov Tamarkin
Naomi Feiman
David Schuz
Tal Berman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foamix Ltd
Original Assignee
Foamix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/481,596 external-priority patent/US8119150B2/en
Priority claimed from US11/488,989 external-priority patent/US10117812B2/en
Priority claimed from US11/717,897 external-priority patent/US8119109B2/en
Application filed by Foamix Ltd filed Critical Foamix Ltd
Priority to EP07848880A priority Critical patent/EP2029106A2/fr
Publication of WO2008038140A2 publication Critical patent/WO2008038140A2/fr
Publication of WO2008038140A3 publication Critical patent/WO2008038140A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un support pharmaceutique expansible comprenant alkyle éther de polypropylène glycol (PPG), une eau agent tensio-actif et un propulseur de gaz d'hydrocarbure liquéfié; ainsi que des compositions pharmaceutiques de ceux-ci. L'invention concerne en outre un support pharmaceutique expansible comprenant alkyle éther de prolypropylène glycol (PPG), un agent tensio-actif, et un propulseur de gaz d'hydrocarbure liquéfié; ainsi que des compositions pharmaceutiques de ceux-ci.
PCT/IB2007/003463 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées Ceased WO2008038140A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07848880A EP2029106A2 (fr) 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US81162706P 2006-06-07 2006-06-07
US60/811,627 2006-06-07
US11/481,596 US8119150B2 (en) 2002-10-25 2006-07-06 Non-flammable insecticide composition and uses thereof
US11/482,596 2006-07-07
US11/488,989 2006-07-19
US11/488,989 US10117812B2 (en) 2002-10-25 2006-07-19 Foamable composition combining a polar solvent and a hydrophobic carrier
US11/717,897 2007-03-13
US11/717,897 US8119109B2 (en) 2002-10-25 2007-03-13 Foamable compositions, kits and methods for hyperhidrosis

Publications (2)

Publication Number Publication Date
WO2008038140A2 WO2008038140A2 (fr) 2008-04-03
WO2008038140A3 true WO2008038140A3 (fr) 2008-09-04

Family

ID=39230597

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003463 Ceased WO2008038140A2 (fr) 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées

Country Status (2)

Country Link
EP (1) EP2029106A2 (fr)
WO (1) WO2008038140A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL1871433T3 (pl) 2005-03-24 2009-09-30 Nolabs Ab Zabieg kosmetyczny z tlenkiem azotu, urządzenie do wykonywania tego zabiegu i sposób jego wytwarzania
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
PT2344198T (pt) 2008-09-27 2020-12-04 Jina Pharmaceuticals Inc Preparações farmacêuticas à base de lípidos para aplicação tópica
US9387160B2 (en) 2008-12-22 2016-07-12 Johnson & Johnson Consumer Holdings France Composition and method of treating skin conditions
PL2210588T3 (pl) 2008-12-23 2011-09-30 Intendis Gmbh Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
EP2421496A4 (fr) * 2009-04-22 2014-01-15 Agency Science Tech & Res Émulsions pour une administration transdermique
CA3062005C (fr) 2009-08-21 2022-02-15 Novan, Inc. Gels topiques renfermant de l'oxyde nitrique liberant des macromoleculesde polysiloxanegels leurs utilisations
EP2467173B8 (fr) 2009-08-21 2019-06-19 Novan, Inc. Pansements, procédés d'utilisation de ceux-ci et procédés de formation de ceux-ci
WO2011112875A2 (fr) 2010-03-10 2011-09-15 Nuvo Research Inc. Formulation expansible
BR112014000178A2 (pt) 2011-07-05 2017-02-07 Novan Inc composições tópicas
WO2013006613A1 (fr) 2011-07-05 2013-01-10 Novan, Inc. Procédés de fabrication de compositions topiques et appareil afférent
CA2865526C (fr) 2012-03-14 2020-06-23 Novan, Inc. Compositions pharmaceutiques liberant de l'oxyde nitrique
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
FR3004641B1 (fr) * 2013-04-17 2016-01-15 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et une huile polaire (poly)oxyalkylenee
WO2015021382A2 (fr) 2013-08-08 2015-02-12 Novan, Inc. Compositions topiques et procédés d'utilisation de celles-ci
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
AU2015287674B2 (en) 2014-07-11 2019-11-21 Ligand Pharmaceuticals Incorporated Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
CN105813617B (zh) 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
WO2017019535A2 (fr) 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Procédés pour l'administration lymphatique de principes actifs
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
WO2017023622A1 (fr) * 2015-08-06 2017-02-09 The Dial Corporation Compositions anti-transpiration contenant des agents de masquage, et procédés de production correspondants
DE102015221568A1 (de) 2015-11-04 2017-05-04 Beiersdorf Ag Kosmetischer Schaum aus einer Emulsion enthaltend Glycerin und Alkohol
WO2017151905A1 (fr) 2016-03-02 2017-09-08 Novan, Inc. Compositions destinées à traiter l'inflammation et méthodes de traitement associées
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
CN109715251B (zh) * 2016-09-19 2024-06-21 宝洁公司 用以改善对皮肤的感觉有益效果的泡沫组合物、气溶胶产品及其使用方法
EP3743047A1 (fr) * 2018-01-26 2020-12-02 The Procter & Gamble Company Procédés et compositions pour réduire la sensation de sécheresse vaginale
EP3743044A1 (fr) * 2018-01-26 2020-12-02 The Procter & Gamble Company Procédés et compositions pour réduire la sensation de sécheresse vaginale
JP2021515807A (ja) 2018-03-01 2021-06-24 ノーバン，インク． 一酸化窒素放出性坐剤及びその使用の方法
GB2574022A (en) * 2018-05-22 2019-11-27 Thornton & Ross Ltd A pediculicidal shampoo
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
WO2020089467A1 (fr) 2018-11-02 2020-05-07 UNION therapeutics A/S Régime posologique
EP3873481A1 (fr) 2018-11-02 2021-09-08 UNION therapeutics A/S Salicylanilides halogénés pour le traitement des symptômes de dermatite
DE102018009781A1 (de) * 2018-12-13 2020-06-18 Valeopharm GmbH Verschäumbare wässrige Zubereitungen auf natürlicher Biopolymerbasis mit einsatzflexibler Gas(- vor allem Sauerstoffgas)-Speicherzellen-Verteilung
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
USD998474S1 (en) 2020-11-25 2023-09-12 The Procter & Gamble Company Aerosol dispenser
USD1015881S1 (en) 2021-05-03 2024-02-27 The Procter & Gamble Company Aerosol foam dispenser
WO2022235542A1 (fr) * 2021-05-03 2022-11-10 The Procter & Gamble Company Compositions de mousse
WO2022235600A1 (fr) 2021-05-03 2022-11-10 The Procter & Gamble Company Distributeur de mousse aérosol

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
EP1287813A1 (fr) * 2001-08-28 2003-03-05 Coty Inc. Emulsion déodorante contre la transpiration
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1428521A2 (fr) * 2002-12-13 2004-06-16 Unilever Plc Composition antitranspirante ou déodorante
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
WO2007099396A2 (fr) * 2005-06-07 2007-09-07 Foamix Ltd. Kit et composition antibiotiques et leurs utilisations

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1287813A1 (fr) * 2001-08-28 2003-03-05 Coty Inc. Emulsion déodorante contre la transpiration
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
EP1428521A2 (fr) * 2002-12-13 2004-06-16 Unilever Plc Composition antitranspirante ou déodorante
WO2007099396A2 (fr) * 2005-06-07 2007-09-07 Foamix Ltd. Kit et composition antibiotiques et leurs utilisations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
US9198858B2 (en) 2011-06-28 2015-12-01 Watson Pharmaceuticals, Inc. Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations

Also Published As

Publication number Publication date
EP2029106A2 (fr) 2009-03-04
WO2008038140A2 (fr) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2008038140A3 (fr) Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées
IN2014DN07569A (fr)
WO2007053675A3 (fr) Agents gonflants concus pour produire une mousse et comprenant des fluorocarbures insatures
EP2327753A3 (fr) Agents propulseurs d'aérosol comprenant des fluorocarbures insaturés
ATE514340T1 (de) Schaumbildendes, komprimiertes gas enthaltendes lösliches kaffeepulver
WO2010040019A3 (fr) Compositions pour mousses résistant à l'abrasion et procédés de fabrication de celles-ci
MXPA05008479A (es) Espuma hidroalcoholica formadora de pelicula.
WO2006023627A8 (fr) Polymorphes de rapamycine et leurs utilisations
ZA200904540B (en) Pressurized can, such as an aerosol can
NO20035249D0 (no) Trykksatt fluidtank, spesielt komprimert gasstank for motorkjöretöy
WO2008067028A3 (fr) Mousses à haute teneur en alcool
PL1791438T3 (pl) Sproszkowana, rozpuszczalna/ rozpraszana w zimnej wodzie, spienialna kompozycja
WO2006026657A3 (fr) Procede de reduction du point de congelation de l'essence aminee dans le secteur aeronautique par utilisation d'une amylphenylamine tertiaire
WO2006136279A3 (fr) Agent formant du gaz destine a une composition de ciment
IL162412A0 (en) Foamable compositions, processes of preparing sameand uses thereof
WO2009021036A3 (fr) Mousses de polyuréthane souples ignifugées et formulations de mousses de polyuréthane souples
MX2007007550A (es) Composiciones de espuma de poliestireno expandido, retardadoras de la flama.
WO2009154374A3 (fr) Armatures métal-organique poreuses permanentes présentant une structure topologique nbo-net renfermant un groupe azo donneur d’électrons et contenant de gaz comprenant ces armatures
WO2010045435A3 (fr) Composition d’acide salicylique
WO2007078679A3 (fr) Synthèse pratique et économique d'ubiquinones
WO2007038564A3 (fr) Manipulation du mecanisme global de transcription
PL354299A1 (en) Gas tank, particularly for liquid propane-butane gas
WO2006004613A3 (fr) Sels de guanylhydrazone, compositions a base de ceux-ci, procedes et production et d'utilisation de ceux-ci
WO2007078771A3 (fr) Articles de diffusion de gaz pour pile a combustible
RU2000121195A (ru) Пенообразователь для вспенивания газового конденсата

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007848880

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848880

Country of ref document: EP

Kind code of ref document: A2